The Armenian government decided Thursday, July 16, to organize the 2015-2019 purchasing process of insulin, aiming to meet the demand of antidiabetic drugs for children and youth diagnosed with diabetes to help improve their health condition.

450 children with diabetes are currently registered in Armenia.

The documents attached to the project envisage payment of $1.891.999 to acquire insulin for the coming 5 years, provided that Eli Lilly and Company implements an investment project worth $427.625.

Currently, the state provides diabetic children with short-acting insulin vials that have no therapeutic effect, as 68% of children and young people are having hypoglycemia seizures at least once a year and are being hospitalized.